✦ LIBER ✦

Morphology and mechanical stability of amyloid-like peptide fibrils

✍ Scribed by Patrick Mesquida; Christian K. Riener; Cait E. MacPhee; Rachel A. McKendry

Publisher: Springer
Year: 2007
Tongue: English
Weight: 343 KB
Volume: 18
Category: Article
ISSN: 0957-4530
DOI: 10.1007/s10856-006-0075-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design of Peptides That Form Amyloid-Lik

Design of Peptides That Form Amyloid-Like Fibrils Capturing Amyloid β1–42 Peptides

✍ Junichi Sato; Tsuyoshi Takahashi; Hideo Oshima; Sachiko Matsumura; Hisakazu Miha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 1 views

Preparation of Phosphorescent Amyloid-Li

Preparation of Phosphorescent Amyloid-Like Protein Fibrils

✍ Aurora Rizzo; Olle Inganäs; Niclas Solin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

l-Ala Modified Analogues of Amyloid β-Pe

l-Ala Modified Analogues of Amyloid β-Peptide Residue 17-20: Self-Association and Amyloid-like Fibril Formation

✍ Debasish Haldar; Arindam Banerjee 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 299 KB

Structure and morphology of the Alzheime

Structure and morphology of the Alzheimer's amyloid fibril

✍ Thusnelda Stromer; Louise C. Serpell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 1 views

## Abstract Amyloid fibrils are deposited in a number of diseases, including Alzheimer's disease, Type 2 diabetes, and the transmissible spongiform encephalopathies (TSE). These insoluble deposits are formed from normally soluble proteins that assemble to form fibrous aggregates that accumulate in

Mechanical and Morphological Properties

Mechanical and Morphological Properties of Cellulose Fibril Reinforced Nanocomposites

✍ T. Zimmermann; E. Pöhler; P. Schwaller 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Stability of amyloid-β peptides in plasm

Stability of amyloid-β peptides in plasma and serum

✍ Mirko Bibl; Volker Welge; Hermann Esselmann; Jens Wiltfang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

## Abstract Plasma amyloid‐β peptide (Aβ) levels have been suggested as a biomarker candidate for detecting incipient AD. Aβ peptides are known to be sensitive to distinct preanalytical sample handling, which calls for standardised preanalytical procedures. We investigated serum and plasma samples